Replies to post #40415 on $heff's $tation of $tocks & $olid DD

[$heff]

PLX..$9.60 Solid 8-K regarding the Interim results from the switchover trial. This data clearly supports the safety and maintenance of efficacy of taliglucerase alfa. This should give the FDA additional support to approve the drug for Gaucher's Disease.

http://bit.ly/gIxC9l

[Investor100]

New Website @ PLX

http://www.protalix.com/about-protalix/overview-about-protalix.asp

Investor 100